Remove Blogging Remove Pricing Remove Startup Remove Study
article thumbnail

Are MBAs Necessary for Start-ups or VC?

Both Sides of the Table

This is part of my ongoing series called “ Start-up Lessons.&#. I was reading Chris Dixon’s blog tonight. I came across this blog post about getting a computer science degree as the best degree for getting into venture capital or working at a VC-backed start up. MBA fine, but not required.

Startup 337
article thumbnail

What Does the Post Crash VC Market Look Like?

Both Sides of the Table

At our mid-year offsite our partnership at Upfront Ventures was discussing what the future of venture capital and the startup ecosystem looked like. This happens slowly because while public markets trade daily and prices then adjust instantly, private markets don’t get reset until follow-on financing rounds happen which can take 6–24 months.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

Xconomy

Biogen’s (NASDAQ: BIIB ) earnings call this week was the first since its Alzheimer’s drug aducanumab failed in a Phase 3 study and eviscerated the company’s shares. But he also pointed to moves the company has made to shore up its multiple sclerosis franchise and add drug candidates in other therapeutic areas.

News 94
article thumbnail

Startups Are A Remix

InfoChachkie

So they don’t have enough dots to connect, and they end up with very linear solutions without a broad perspective on the problem. Everything Is A Remix – Including Your Startup. Nobody starts out original. Like music, movies and blog entries, startups are a remix of that which came before. emphasis added).

Startup 255
article thumbnail

Netflix Redux: Is It Ever OK to Fire Your Customers?

Both Sides of the Table

The big price increase : 5 out of 5 stars. Some customer segments value the DVD business and these may be more price sensitive. They might be willing to pay higher prices (and perhaps not an “all you can eat” price but a “pay as you go” price per film). A blog post! No, probably not.

Netflix 287
article thumbnail

Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours

Xconomy

The San Francisco company priced its IPO late Tuesday, selling 6.25 Eidos will use the cash to fund studies of AG10 , a drug in mid-stage testing for transthyretin (TTR) amyloidosis, a progressive and fatal condition caused by the. The first was Eidos Therapeutics (NASDAQ: EIDX ), which raised $106 million in its stock market debut.

Study 72
article thumbnail

Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More

Xconomy

As part of the Obama administration’s “cancer moonshot” program, a panel of scientists this week presented a set of broad, ambitious recommendations to speed up the pace of cancer research, treatment, and prevention. For more on that and the rest of the week’s news, fire up the roundup rockets.

Pricing 40